Role of linezolid therapeutic drug monitoring in the treatment of MRSA tracheo-pulmonary infection in a 10-month-old infant

Research output: Contribution to journalArticle


The paper reports on the use of therapeutic drug monitoring for linezolid in the decision-making process to continue or not its administration in an infant. Linezolid is effective against methicillin-resistant Staphylococcus aureus but is off-label in pediatrics. The use of therapeutic drug monitoring, as in our case, allows an informed decision on administration of the drug (in this case on withdrawal) increasing patients safety.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalJournal of Chemotherapy
Publication statusAccepted/In press - Jul 24 2016



  • Linezolid
  • Paediatrics
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Infectious Diseases
  • Pharmacology (medical)

Cite this